Home＜ Investor Relations

Investor Relations

Company Profile Corporate Governance
Information Disclosure
Announcements and Circulars Financial Reports and ESG Reports The Listed Files
Presentations & Webcasts Investor Relations Query
2020.12
28

Next Day Disclosure Returns

2020.12
04

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2020

2020.11
11

CERTAIN UNAUDITED FINANCIAL INFORMATION FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2020

2020.11
05

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2020

2020.10
27

CHANGE IN USE OF NET PROCEEDS FROM THE GLOBAL OFFERING

2020.10
15

APPOINTMENT OF VICE CHAIRMAN OF THE BOARD AND CHIEF EXECUTIVE OFFICER AND CHANGE OF AUTHORISED REPRESENTATIVE

2020.10
08

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2020

2020.09
04

VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF NEW DRUG APPLICATION FOR BEVACIZUMAB INJECTION (TAB008, A BIOSIMILAR TO AVASTIN) BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION

2020.09
04

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2020